Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn

British Journal of Haematology

Volumn 176, Issue 4, 2017, Pages 651-660

  Sonneveld, Myrthe E ^a   Koelewijn, Joke ^b   de Haas, Masja ^b,c   Admiraal, Jon ^a   Plomp, Rosina ^c   Koeleman, Carolien A M ^c   Hipgrave Ederveen, Agnes L ^c   Ligthart, Peter ^b   Wuhrer, Manfred ^c   van der Schoot, C Ellen ^a   Vidarsson, Gestur ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibodies; Fc glycosylation; Haemolytic anaemia; Immunology; Red cell antigens

Indexed keywords

ALLOANTIBODY; ERYTHROCYTE ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN C ANTIBODY; IMMUNOGLOBULIN D ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN K ANTIBODY; UNCLASSIFIED DRUG; BLOOD GROUP ANTIGEN;

ALLOIMMUNIZATION; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FUCOSYLATION; GLYCOSYLATION; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MATERNAL SERUM; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PHOTOTHERAPY; PREGNANT WOMAN; PROSPECTIVE STUDY; RISK FACTOR; SIALYLATION; ADULT; BLOOD; ERYTHROBLASTOSIS, FETAL; ERYTHROCYTE; IMMUNOLOGY; MALE; METABOLISM; PREGNANCY; SEVERITY OF ILLNESS INDEX;

ADULT; BLOOD GROUP ANTIGENS; ERYTHROBLASTOSIS, FETAL; ERYTHROCYTES; FEMALE; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; INFANT, NEWBORN; ISOANTIBODIES; MALE; PREGNANCY; SEVERITY OF ILLNESS INDEX;

EID: 85005777560     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14438     Document Type: Article

References (37)

1. Ackerman, M.E., Crispin, M., Yu, X., Baruah, K., Boesch, A.W., Harvey, D.J., Dugast, A.S., Heizen, E.L., Ercan, A., Choi, I., Streeck, H., Nigrovic, P.A., Bailey-Kellogg, C., Scanlan, C. & Alter, G. (2013) Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. The Journal of Clinical Investigation, 123, 2183–2192.
2. Anthony, R.M. & Nimmerjahn, F. (2011) The role of differential IgG glycosylation in the interaction of antibodies with FcgammaRs in vivo. Current Opinion in Organ Transplantation, 16, 7–14.
3. Daniels, G., Hadley, A. & Green, C.A. (2003) Causes of fetal anemia in hemolytic disease due to anti-K. Transfusion, 43, 115–116.
4. Deng, Z.H., Seltsam, A., Ye, Y.W., Yu, Q., Li, Q., Su, Y.Q., Liang, Y.L. & Zang, H. (2008) Haemolytic disease of fetus and newborn caused by ABO antibodies in a cisAB offspring. Transfusion and Apheresis Science, 39, 123–128.
5. Echeverria, B., Etxebarria, J., Ruiz, N., Hernandez, A., Calvo, J., Haberger, M., Reusch, D. & Reichardt, N.C. (2015) Chemo-Enzymatic Synthesis of (13)C Labeled Complex N-Glycans As Internal Standards for the Absolute Glycan Quantification by Mass Spectrometry. Analytical Chemistry, 87, 11460–11467.
6. Einarsdottir, H.K., Selman, M.H., Kapur, R., Scherjon, S., Koeleman, C.A., Deelder, A.M., van der Schoot, C.E., Vidarsson, G. & Wuhrer, M. (2013) Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G. Glycoconjugate Journal, 30, 147–157.
7. Ferrara, C., Grau, S., Jager, C., Sondermann, P., Brunker, P., Waldhauer, I., Hennig, M., Ruf, A., Rufer, A.C., Stihle, M., Umana, P. & Benz, J. (2011) Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proc Natl Acad Sci U S A, 108, 12669–12674.
8. Fokkink, W.J., Selman, M.H., Dortland, J.R., Durmus, B., Kuitwaard, K., Huizinga, R., van Rijs, W., Tio-Gillen, A.P., van Doorn, P.A., Deelder, A.M., Wuhrer, M. & Jacobs, B.C. (2014) IgG Fc N-glycosylation in Guillain-Barre syndrome treated with immunoglobulins. Journal of Proteome Research, 13, 1722–1730.
9. Goldman, M., Lane, D., Webert, K. & Fallis, R. (2015) The prevalence of anti-K in Canadian prenatal patients. Transfusion, 55, 1486–1491.
10. de Haas, M., Thurik, F.F., Koelewijn, J.M. & van der Schoot, C.E. (2015) Haemolytic disease of the fetus and newborn. Vox Sanguinis, 109, 99–113.
11. Houde, D., Peng, Y., Berkowitz, S.A. & Engen, J.R. (2010) Post-translational modifications differentially affect IgG1 conformation and receptor binding. Molecular & Cellular Proteomics: MCP, 9, 1716–1728.
12. Huffman, J.E., Pucic-Bakovic, M., Klaric, L., Hennig, R., Selman, M.H., Vuckovic, F., Novokmet, M., Kristic, J., Borowiak, M., Muth, T., Polasek, O., Razdorov, G., Gornik, O., Plomp, R., Theodoratou, E., Wright, A.F., Rudan, I., Hayward, C., Campbell, H., Deelder, A.M., Reichl, U., Aulchenko, Y.S., Rapp, E., Wuhrer, M. & Lauc, G. (2014) Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. Molecular & Cellular Proteomics: MCP, 13, 1598–1610.
13. Kamphuis, M.M., Lindenburg, I., van Kamp, I.L., Meerman, R.H., Kanhai, H.H. & Oepkes, D. (2008) Implementation of routine screening for Kell antibodies: does it improve perinatal survival? Transfusion, 48, 953–957.
14. Kapur, R., Della Valle, L., Sonneveld, M., Hipgrave, E.A., Visser, R., Ligthart, P., de Haas, M., Wuhrer, M., van der Schoot, C.E. & Vidarsson, G. (2014) Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn. British Journal of Haematology, 166, 936–945.
15. Kapur, R., Della Valle, L., Verhagen, O.J., Hipgrave Ederveen, A., Ligthart, P., de Haas, M., Kumpel, B., Wuhrer, M., van der Schoot, C.E. & Vidarsson, G. (2015) Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D. Transfusion, 55, 553–562.
16. Karsten, C.M., Pandey, M.K., Figge, J., Kilchenstein, R., Taylor, P.R., Rosas, M., McDonald, J.U., Orr, S.J., Berger, M., Petzold, D., Blanchard, V., Winkler, A., Hess, C., Reid, D.M., Majoul, I.V., Strait, R.T., Harris, N.L., Kohl, G., Wex, E., Ludwig, R., Zillikens, D., Nimmerjahn, F., Finkelman, F.D., Brown, G.D., Ehlers, M. & Kohl, J. (2012) Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nature Medicine, 18, 1401–1406.
17. Koelewijn, J.M., Vrijkotte, T.G., van der Schoot, C.E., Bonsel, G.J. & de Haas, M. (2008a) Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion, 48, 941–952.
18. Koelewijn, J.M., de Haas, M., Vrijkotte, T.G., Bonsel, G.J. & van der Schoot, C.E. (2008b) One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Transfusion, 48, 1721–1729.
19. Koelewijn, J.M., de Haas, M., Vrijkotte, T.G., van der Schoot, C.E. & Bonsel, G.J. (2009) Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis. BJOG, 116, 1307–1314.
20. Mizushima, T., Yagi, H., Takemoto, E., Shibata-Koyama, M., Isoda, Y., Iida, S., Masuda, K., Satoh, M. & Kato, K. (2011) Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans. Genes To Cells: Devoted To Molecular & Cellular Mechanisms, 16, 1071–1080.
21. Moise, K.J. (2008) Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Seminars in Fetal & Neonatal Medicine, 13, 207–214.
22. Moise, K.J. Jr & Argoti, P.S. (2012) Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstetrics and gynecology, 120, 1132–1139.
23. Oepkes, D., van Kamp, I.L., Simon, M.J., Mesman, J., Overbeeke, M.A. & Kanhai, H.H. (2001) Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization. American Journal of Obstetrics and Gynecology, 184, 1015–1020.
24. Oepkes, D., Seaward, P.G., Vandenbussche, F.P., Windrim, R., Kingdom, J., Beyene, J., Kanhai, H.H., Ohlsson, A. & Ryan, G.; for the DIAMOND Study Group. (2006) Doppler ultrasonography versus amniocentesis to predict fetal anemia. The New England Journal of Medicine, 355, 156–164.
25. Ruhaak, L.R. & Lebrilla, C.B. (2015) Applications of Multiple Reaction Monitoring to Clinical Glycomics. Chromatographia, 78, 335–342.
26. Ruhaak, L.R., Uh, H.W., Deelder, A.M., Dolhain, R.E. & Wuhrer, M. (2014) Total plasma N-glycome changes during pregnancy. Journal of Proteome Research, 13, 1657–1668.
27. Selman, M.H., de Jong, S.E., Soonawala, D., Kroon, F.P., Adegnika, A.A., Deelder, A.M., Hokke, C.H., Yazdanbakhsh, M. & Wuhrer, M. (2012) Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination. Molecular & Cellular Proteomics: MCP, 11, 014563.
28. Sonneveld, M.E., van der Schoot, C.E. & Vidarsson, G. (2016a) The Elements Steering Pathogenesis in IgG-Mediated Alloimmune Diseases. Journal of Clinical Immunology, 36, 76–81.
29. Sonneveld, M.E., Natunen, S., Sainio, S., Koeleman, C.A., Holst, S., Dekkers, G., Koelewijn, J., Partanen, J., van der Schoot, C.E., Wuhrer, M. & Vidarsson, G. (2016b) Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia. British Journal of Haematology, 174, 310–320.
30. Stavenhagen, K., Hinneburg, H., Thaysen-Andersen, M., Hartmann, L., Varon Silva, D., Fuchser, J., Kaspar, S., Rapp, E., Seeberger, P.H. & Kolarich, D. (2013) Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides. Journal of Mass Spectrometry, 48, 627–639.
31. Thomann, M., Schlothauer, T., Dashivets, T., Malik, S., Avenal, C., Bulau, P., Ruger, P. & Reusch, D. (2015) In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity. PLoS ONE, 10, e0134949.
32. Varadi, C., Lew, C. & Guttman, A. (2014) Rapid magnetic bead based sample preparation for automated and high throughput N-glycan analysis of therapeutic antibodies. Analytical Chemistry, 86, 5682–5687.
33. Vaughan, J.I., Manning, M., Warwick, R.M., Letsky, E.A., Murray, N.A. & Roberts, I.A. (1998) Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. New England Journal of Medicine, 338, 798–803.
34. Vestrheim, A.C., Moen, A., Egge-Jacobsen, W., Reubsaet, L., Halvorsen, T.G., Bratlie, D.B., Paulsen, B.S. & Michaelsen, T.E. (2014) A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines. Immunity, Inflammation and Disease, 2, 76–91.
35. Wuhrer, M., Porcelijn, L., Kapur, R., Koeleman, C.A., Deelder, A., de Haas, M. & Vidarsson, G. (2009) Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens. Journal of Proteome Research, 8, 450–456.
36. Yu, X., Vasiljevic, S., Mitchell, D.A., Crispin, M. & Scanlan, C.N. (2013) Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain. Journal of Molecular Biology, 425, 1253–1258.
37. Zheng, K., Bantog, C. & Bayer, R. (2011) The impact of glycosylation on monoclonal antibody conformation and stability. MAbs, 3, 568–576.